SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-24-001128 to SUNHYDROGEN, INC. (HYSR) (CIK 0001481028) (HYSR)

SUNHYDROGEN, INC. (HYSR) (CIK 0001481028)
Date: Jan. 30, 2024 · CIK: 0001481028 · Accession: 0000000000-24-001128

AI Filing Summary & Sentiment

File numbers found in text: 333-276678

Date
January 30, 2024
Author
Not clearly detected
Form
UPLOAD
Company
SUNHYDROGEN, INC. (HYSR) (CIK 0001481028)

Letter

United States securities and exchange commission logo January 30, 2024 Timothy Young Chief Executive Officer SunHydrogen, Inc. BioVentures Center 2500 Crosspark Road Coralville, IA 52241 Re:SunHydrogen, Inc. Registration Statement on Form S-3 Filed January 24, 2024 File No. 333-276678 Dear Timothy Young: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Eranga Dias at 202-551-8107 with any questions. Sincerely, Division of Corporation Finance Office of Manufacturing

Show Raw Text
United States securities and exchange commission logo
January 30, 2024
Timothy Young
Chief Executive Officer
SunHydrogen, Inc.
BioVentures Center
2500 Crosspark Road
Coralville, IA 52241
Re:SunHydrogen, Inc.
Registration Statement on Form S-3
Filed January 24, 2024
File No. 333-276678
Dear Timothy Young:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Eranga Dias at 202-551-8107 with any questions.
Sincerely,
Division of Corporation Finance
Office of Manufacturing